Latest Blogs

Aug 11, 2022
Dr. Tara Rajendran celebrates the legacy and mentorship of Dr. Karen Jean Marcus upon her retirement after 33-year career at the Dana-Farber Cancer Institute.
Jul 27, 2022
Dr. Anna M Laucis discusses the landscape and future opportunities for narrative medicine, along with her own explorations in original artwork and poetry.
Jul 21, 2022
It feels great to celebrate 17 consecutive years of organizing the Best of ASCO Lebanon meeting, including a well-received event featuring expert faculty in 2022.
Jul 20, 2022
The weeks following the ASCO Annual Meeting always feel like a bit of a reset, as we emerge energized from connecting with friends and colleagues.
Subscribe to this column

Gilberto Lopes, MD, FASCO, MBA

Gilberto de Lima Lopes Jr., MD, MBA, FAMS, is associate director for global oncology and interim chief for the Division of Medical Oncology at the Sylvester Comprehensive Cancer Center and professor of clinical medicine at the University of Miami in Florida. He returned to the United States after 10 years in Asia and Latin America and has dedicated much of his time to the issues of cancer control and access to medications in low- and middle-income countries. Dr. Lopes is the editor-in-chief for JCO Global Oncology, among other volunteer roles at ASCO. Follow him on Twitter @GlopesMd.

Disclosure.

Dec 16, 2021
Grief is a process. We read about it, we receive training on it, we live it.
Mar 25, 2020
My coauthors and I call on every oncology caregiver and stakeholder to join us in the fight against our lack of information and help us gather the data that will be paramount to guide our practices in this new reality.
Jun 11, 2019
I am excited about the entire Breakthrough program, including a session I am leading on the impact of social media and telehealth on cancer care.
Nov 27, 2018
By 2030, the number of deaths due to lung cancer is expected to almost double for Latin American women and increase by 50% for Latin American men.
Nov 09, 2018
My coauthors and I focus on health disparities using specific countries across the income spectrum to highlight the challenges encountered by health officials, physicians, and patients at each level.
Nov 20, 2017
A journal that aims to be the voice of global oncology has to publish work relating not only to differences in cancer biology due to risk factors, pathogenesis, and pharmacology, but also disparities arising from social, cultural, economic, and political resource-constraining issues.

Pages